Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Clozapine (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Clozapine (administration & dosage) < Clozapine (adverse effects) < Clozapine (metabolism)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000138 (1999) E S Molho [États-Unis] ; S A FactorPossible tardive dystonia resulting from clozapine therapy.
000286 (2000) H H Fernandez [États-Unis] ; M C Lannon ; J H Friedman ; B P AbbottClozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
000421 (2000) M. Serrano-Due AsAtypical antipsychotics: clozapine-related cardiac complications.
000957 (2002) Theresa A. Zesiewicz [États-Unis] ; Sujatha Borra ; Robert A. HauserClozapine withdrawal symptoms in a Parkinson's disease patient.
000988 (2003) Joseph H. FriedmanRe: Klintenberg et al, tardive dyskinesia model in the common marmoset.
000B38 (1992) S A Factor [États-Unis] ; D. BrownClozapine prevents recurrence of psychosis in Parkinson's disease.
001022 (2005) Hubert H. Fernandez [États-Unis] ; Martha E. Trieschmann ; Michael S. OkunRebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease.
001191 (2005) Spiridon Papapetropoulos ; Deborah C. MashThe neurochemical mechanism of rebound psychosis in Parkinson's disease.
004812 (1994) J H Friedman [États-Unis]Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
004818 (1994) J P Bennett ; E R Landow ; S. Dietrich ; L A SchuhSuppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction.
004823 (1994) J M Trugman ; R. Leadbetter ; M E Zalis ; R O Burgdorf ; G F WootenTreatment of severe axial tardive dystonia with clozapine: case report and hypothesis.
004A12 (1993) G. Linazasoro [Espagne] ; J F Martí Mass ; J A SuárezNocturnal akathisia in Parkinson's disease: treatment with clozapine.
004F47 (1998) R M Trosch [États-Unis] ; J H Friedman ; M C Lannon ; R. Pahwa ; D. Smith ; L C Seeberger ; C F O'Brien ; P A Lewitt ; W C KollerClozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience.
004F83 (1998) H H Fernandez [États-Unis] ; R. DursoClozapine for dopaminergic-induced paraphilias in Parkinson's disease.
004F91 (1998) I. Maurer [Allemagne] ; T. Grunwald ; C E ElgerClozapine treatment of delayed-onset paroxysmal hemidystonia.
005107 (1999) G. Lera [Argentine] ; J. ZirulnikPilot study with clozapine in patients with HIV-associated psychosis and drug-induced parkinsonism.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Clozapine (adverse effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Clozapine (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Clozapine (adverse effects)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024